1 Jaffray J,Witmer C,O'Brien S H,et al.Peripherally inserted central catheters lead to a high risk of venous thromboembolism in children.Blood,2020,135:220-226. 2 Madabhavi I,Patel A,Sarkar M,et al.A study of the use of peripherally inserted central catheters in cancer patients:A single-center experience.J Vasc Nurs,2018,36:149-156. 3 Borretta L,MacDonald T,Digout C,et al.Peripherally Inserted central catheters in pediatric oncology patients:a 15-year population-based review from Maritimes,Canada.J Pediatr Hematol Oncol,2018,40:e55-e60. 4 Citla SD,Abou-Ismail MY,Ahuja SP.Central venous catheter-related thrombosis in children and adults.Thromb Res,2020,187:103-112. 5 Ostlund A,Flaring U,Norberg A,et al.Incidence of and risk factors for venous thrombosis in children with percutaneous non-tunnelled central venous catheters.Br J Anaesth,2019,123:316-324. 6 Smolyar AN,Ginzburg LM,Smirnov MA.Totally implantable central venous port:analysis of complications and their prevention.Khirurgiia (Mosk),2019:13-17. 7 Noonan PJ,Hanson SJ,Simpson PM,et al.Comparison of complication rates of central venous catheters versus peripherally inserted central venous catheters in pediatric patients.Pediatr Crit Care Med,2018,19:1097-1105. 8 Rykov MY,Zaborovskij SV,Shvecov AN,et al.Peripherally inserted central catheters in the treatment of children with cancer:Results of a multicenter study.J Vasc Access,2018,19:378-381. 9 Sharathkumar AA,Biss T,Kulkarni K,et al.Epidemiology and outcomes of clinically unsuspected venous thromboembolism in children:A systematic review.J Thromb Haemost,2020,18:1100-1112. 10 Takano S,Shimizu N,Tokuyasu N,et al.Comparative study of complications in cv catheter insertion for pediatric patients:real-time ultrasound-guided versus venography-guided approach.Yonago Acta Med,2017,60:234-240. 11 Ruhle F,Stoll M.Advances in predicting venous thromboembolism risk in children.Br J Haematol,2018,180:654-665. 12 Monagle P,Cuello CA,Augustine C,et al.American Society of Hematology 2018 Guidelines for management of venous thromboembolism:treatment of pediatric venous thromboembolism.Blood Adv,2018,2:3292-3316. 13 Kahale LA,Tsolakian IG,Hakoum MB,et al.Anticoagulation for people with cancer and central venous catheters.Cochrane Database Syst Rev,2018,6:64-68. 14 Biss TT.Venous Thromboembolism in children:is it preventable?.Semin Thromb Hemost,2016,42:603-611. 15 Jaffray J,Goldenberg N.Current approaches in the treatment of catheter-related deep venous thrombosis in children.Expert Rev Hematol,2020,13:607-617. 16 Bosch A,Albisetti M.Management of venous thromboembolism in children:current recommendations and therapeutic options.Ther Clin Risk Manag,2020,16:673-679. 17 Ranta S,Tuckuviene R,Makipernaa A,et al.Cerebral sinus venous thromboses in children with acute lymphoblastic leukaemia-a multicentre study from the Nordic Society of Paediatric Haematology and Oncology.Br J Haematol,2015,168:547-552. 18 Meier KA,Tarango C.Treatment of pediatric venous thromboembolism.J Hosp Med,2019,14:497-498. 19 Lutwick L,Al-Maani AS,Mehtar S,et al.Managing and preventing vascular catheter infections:A position paper of the international society for infectious diseases.Int J Infect Dis,2019,84:22-29. 20 Bell T,O'Grady NP.Prevention of central line-associated bloodstream infections.Infect Dis Clin North Am,2017,31:551-559. 21 Steiner M,Langgartner M,Cardona F,et al.Significant reduction of catheter-associated blood stream infections in preterm neonates after implementation of a care bundle focusing on simulation training of central line insertion.Pediatr Infect Dis J,2015,34:1193-1196. 22 Bakan AB,Arli SK.Development of the peripheral and central venous catheter-related bloodstream infection prevention knowledge and attitudes scale.Nurs Crit Care.2021,26:35-41. 23 Lutwick L,Al-Maani AS,Mehtar S,et al.Managing and preventing vascular catheter infections:A position paper of the international society for infectious diseases.Int J Infect Dis,2019,84:22-29. 24 McAlearney AS,Hefner J,Robbins J,et al.Toward a high-performance management system in health care,part 4:Using high-performance work practices to prevent central line-associated blood stream infections-a comparative case study.Health Care Manage Rev,2016,41:233-243. 25 Zipursky AR,Yoon EW,Emberley J,et al.Central line-associated blood stream infections and non-central line-associated blood stream infections surveillance in Canadian tertiary care neonatal intensive care units.J Pediatr,2019,208:176-182. 26 Rosenthal VD,Al-Abdely HM,El-Kholy AA,et al.International Nosocomial Infection Control Consortium report,data summary of 50 countries for 2010-2015:Device-associated module.Am J Infect Control,2016,44:1495-1504. 27 Rosenthal VD,Desse J,Maurizi DM,et al.Impact of the international nosocomial infection control consortium (INICC)'s multidimensional approach on rates of central line-associated bloodstream infection in 14 intensive care units in 11 hospitals of 5 cities in Argentina.Infect Control Hosp Epidemiol,2018,39:445-451. 28 Bouzidi H,Emirian A,Marty A,et al.Differential time to positivity of central and peripheral blood cultures is inaccurate for the diagnosis of Staphylococcus aureus long-term catheter-related sepsis.J Hosp Infect,2018,99:192-199. 29 Kramer RD,Rogers MA,Conte M,et al.Are antimicrobial peripherally inserted central catheters associated with reduction in central line-associated bloodstream infection? A systematic review and meta-analysis.Am J Infect Control,2017,45:108-114. 30 Iversen K,Ihlemann N,Gill SU,et al.Partial oral versus intravenous antibiotic treatment of endocarditis.N Engl J Med,2019,380:415-424.
